Dec 13, 2017· Comment from Association for Accessible Medicines· FDA-2017-N-5101-0013
Comments from The Association for Accessible Medicines (AAM) regarding Docket FDA-2017-N-5101: Review of Existing Center for Drug Evaluation and Research Regulatory and Information Collection Requirements. See attached file.